LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website: https://business.uoregon.edu/centers/lce

Clinical Trials

Comparison of Contrast Agents During CT Angiography

Not Applicable

Completed

Conditions: Contrast Enhancement on Cardiac CT

Interventions: Diagnostic Test: contrast agent

First Posted Date: 2012-02-17

Last Posted Date: 2018-03-01

Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Target Recruit Count: 513

Registration Number: NCT01534975

Locations: 🇺🇸
Los Angeles Biomedical Research Institute, Torrance, California, United States

Effect of Aged Garlic Extract on Atherosclerosis

Phase 4

Completed

Conditions: Metabolic Syndrome

Interventions: Drug: placebo
Drug: aged garlic extract

First Posted Date: 2012-02-17

Last Posted Date: 2017-04-20

Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Target Recruit Count: 65

Registration Number: NCT01534910

Locations: 🇺🇸
Los Angeles Biomedical Research Institute, Torrance, California, United States

Longitudinal Study of Bone Disease in Children with Mucopolysaccharidoses (MPS) I, II, and VI

Completed

Conditions: Mucopolysaccharidoses

First Posted Date: 2012-01-30

Last Posted Date: 2024-10-22

Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Target Recruit Count: 55

Registration Number: NCT01521429

Locations: 🇺🇸
Children's Hospital & Research Center Oakland, Oakland, California, United States
🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States

Malnutrition, Diet and Racial Disparities in Chronic Kidney Disease (CKD)

Conditions: End-Stage Renal Disease (ESRD)
Chronic Kidney Disease (CKD)

First Posted Date: 2011-08-12

Last Posted Date: 2015-05-21

Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Target Recruit Count: 1050

Registration Number: NCT01415570

Locations: 🇺🇸
Harold Simmons Center for Kidney Disease Research & Epidemiology, Torrance, California, United States

Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates

Phase 1

Completed

Conditions: Retinal Diseases
Optic Nerve Diseases

Interventions: Procedure: OCT imaging.

First Posted Date: 2011-07-28

Last Posted Date: 2017-07-13

Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Target Recruit Count: 20

Registration Number: NCT01404247

Locations: 🇺🇸
Los Angeles Biomedical Research Institute atHarbor-UCLA Medical Center, Torrance, California, United States

Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men

Phase 1

Completed

Conditions: Healthy Men
Male Contraception

Interventions: Drug: Placebo
Drug: Dimethandrolone Undecanoate

First Posted Date: 2011-06-27

Last Posted Date: 2017-07-02

Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Target Recruit Count: 100

Registration Number: NCT01382069

Locations: 🇺🇸
Los Angeles Biomedical Research Institute, Torrance, California, United States
🇺🇸
University of Washington, Seattle, Washington, United States

Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication

Phase 4

Completed

Conditions: Pulmonary Arterial Hypertension

Interventions: Drug: Treprostinil

First Posted Date: 2010-12-31

Last Posted Date: 2017-09-01

Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Target Recruit Count: 6

Registration Number: NCT01268553

Locations: 🇺🇸
Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸
University of CA, San Francisco, San Francisco, California, United States
🇺🇸
University of Arizona, Tucson, Arizona, United States

Fosrenol for Enhancing Dietary Protein Intake in Hypoalbuminemic Dialysis Patients (FrEDI) Study

Not Applicable

Completed

Conditions: End-Stage Renal Disease

Interventions: Other: Meals during hemodialysis accompanied by lanthanum carbonate to control phosphorus

First Posted Date: 2010-05-05

Last Posted Date: 2012-02-29

Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Target Recruit Count: 108

Registration Number: NCT01116947

Early Versus Delayed Surgery for Gallstone Pancreatitis

Not Applicable

Completed

Conditions: Gallstone Pancreatitis

Interventions: Procedure: Laparoscopic cholecystectomy within 48 hours of admission
Procedure: Laparoscopic cholecystectomy after resolution of abdominal pain and laboratory values

First Posted Date: 2009-03-18

Last Posted Date: 2011-09-27

Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Target Recruit Count: 100

Registration Number: NCT00863642

Locations: 🇺🇸
Harbor-UCLA Medical Center, Torrance, California, United States

Firefighter Aged Garlic Extract Investigation With CoQ10 as a Treatment for Heart Disease (FAITH)

Phase 3

Completed

Conditions: Coronary Atherosclerosis
Coronary Stenosis
Coronary Artery Calcification

Interventions: Dietary Supplement: Aged garlic extract and Coenzyme Q10

First Posted Date: 2009-03-12

Last Posted Date: 2015-03-12

Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Target Recruit Count: 65

Registration Number: NCT00860847

Locations: 🇺🇸
Los Angeles Biomedical Research Institute, Torrance, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy